Chelation Therapy
IV & Infusion Therapies

Chelation Therapy

EDTA Chelation Therapy

Intravenous infusion of EDTA (ethylenediaminetetraacetic acid) to bind and remove heavy metals from the bloodstream. FDA-approved for lead poisoning; used off-label for cardiovascular disease with mixed evidence from the TACT trial.

BGRADE · Moderate
30+ Studies40+ ReportsModerateIntravenousAvailable in UAE
52
Kamura ScorePromising
52/100
Promising
Moderate
Evidence
After series of 20-40 sessions
Time to Effect
AED 1,500-4,000/session
Est. Cost
Available
UAE Access
Last reviewed: March 2026
50
Research
55
Safety
58
Access
48
Value

How Chelation Therapy Works

Chelation therapy uses synthetic amino acid compounds (most commonly CaNa2EDTA or DMSA) that bind to heavy metals and minerals in the bloodstream through coordinate covalent bonds, forming stable, water-soluble chelate-metal complexes. These complexes are then excreted through the kidneys. This is a well-established medical treatment for documented heavy metal poisoning (lead, mercury, arsenic). Its use for cardiovascular disease, general 'detox,' or anti-aging is controversial — the TACT trial showed modest benefit in diabetic patients with prior heart attacks, but mainstream cardiology organizations do not recommend it as standard therapy.

📊 Evidence by Outcome

Heavy Metal RemovalA

FDA-approved for lead and heavy metal poisoning. Well-established mechanism of chelation and renal excretion.

15 studies • Consistency: High • Effect: Large

Cardiovascular DiseaseC

TACT trial showed modest benefit in diabetic patients with prior MI, but results were controversial. TACT2 follow-up ongoing.

5 studies • Consistency: Mixed • Effect: Small

📄

Key Research

Peer-Reviewed Evidence • 1 Citations

[1]

Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous MI: TACT

Lamas GA et al.JAMA2013PMID: 23549581

Key Finding: RCT (n=1708) showed modest 18% reduction in composite cardiovascular endpoint, significant benefit in diabetic subgroup (39% reduction).

View on PubMed

Citations sourced from PubMed, Cochrane Library, and peer-reviewed journals. Study findings are summarized for accessibility. Always consult the original publication for full methodology and results.

Side Effects & Safety

Common(5)
Burning sensation at the IV infusion siteHeadache and fatigue during and after treatmentNausea, vomiting, or diarrheaTemporary drop in blood pressureMild fever
Rare(4)
Hypocalcemia (low calcium) causing muscle cramps, numbness, or tinglingDepletion of essential minerals (zinc, copper, iron, manganese)Bone marrow suppression with certain chelating agentsSkin reactions or rash
Serious(4)
Acute kidney failure — chelation agents are nephrotoxic, especially in patients with pre-existing kidney diseaseSevere hypocalcemia leading to cardiac arrhythmias or cardiac arrest (reported with Na2EDTA)Pancytopenia (low blood cell counts) with prolonged useDeath has been reported from improperly administered chelation therapy (rapid IV push of Na2EDTA)

Interactions & Contraindications

Drug Interactions

  • Nephrotoxic drugs (aminoglycosides, NSAIDs) — additive kidney damage risk
  • Insulin and diabetes medications — chelation can affect blood glucose levels
  • Cardiac glycosides (digoxin) — hypocalcemia from chelation can potentiate toxicity
  • Other mineral-depleting medications — additive depletion risk

Supplement Interactions

  • Mineral supplements (zinc, iron, copper) — timing must be separated from chelation sessions to avoid binding and removal
  • Calcium supplements may need to be increased during chelation courses
  • Vitamin C is often co-administered to support the chelation process

Food & Timing

  • Iron-rich foods should be timed away from chelation sessions
  • Adequate hydration is critical to support renal clearance of chelate-metal complexes
  • Nutrient-dense diet essential to compensate for mineral depletion

Who Should Avoid

  • Kidney disease or impaired renal function — chelation agents are renally cleared and nephrotoxic
  • Liver failure — impaired metabolism of chelating agents
  • Pregnancy and breastfeeding — chelating agents cross the placenta and enter breast milk
  • Severe heart failure — fluid volume from IV infusion can cause overload
  • Hypocalcemia — chelation further depletes calcium
  • Children — only under strict medical supervision for documented heavy metal poisoning

📋 Protocol Snapshot

Heavy Metal Detox
1.5-3g EDTA IV, 20-40 sessions over 6-12 months
Monitor kidney function, mineral levels. Supplement calcium, zinc, magnesium.

Protocols are for informational purposes only. Always consult a qualified healthcare provider before starting any treatment protocol.

Cost Guide

AED 1,500-4,000/session

Estimated UAE pricing. Costs vary by provider, dosage, and treatment plan.

Frequently Asked Questions

Yes, for its approved indication: acute heavy metal poisoning (lead, mercury, arsenic, iron overload). This is standard medical practice. Its use for cardiovascular disease, general detoxification, or anti-aging is not supported by mainstream medical organizations, though some integrative practitioners advocate for it based on the TACT trial results.

Yes, several integrative and functional medicine clinics in Dubai and Abu Dhabi offer chelation therapy. For heavy metal detoxification, ensure you have documented elevated levels through proper testing (blood, urine provocation tests) before proceeding. Be cautious of clinics recommending chelation without evidence of metal toxicity.

For documented heavy metal toxicity, protocols typically involve 20-40 sessions over several months, with regular monitoring of kidney function and mineral levels. Each session takes 1-3 hours. For 'wellness' chelation (not evidence-based), clinics may recommend various protocols. Always insist on regular blood work monitoring.

The primary risks are kidney damage and depletion of essential minerals (zinc, copper, iron, calcium). Deaths have occurred from improperly administered chelation. It is critical that chelation be performed by a qualified physician with proper monitoring — kidney function tests, complete blood counts, and mineral levels should be checked regularly throughout treatment.

The TACT trial (2013) found a modest benefit in diabetic patients with prior heart attacks, but results were not conclusive enough for mainstream cardiology organizations to recommend it. A follow-up trial (TACT2) was conducted. Chelation should not replace proven cardiovascular treatments (statins, blood pressure control, lifestyle modification).

Where to Get It (UAE)

Browse all wellness centers →

Medical Disclaimer: The information on this page is for educational purposes only and is not intended as medical advice. Kamura Scores reflect a combination of research evidence, safety, accessibility, and value — they are not clinical recommendations. Research citations are provided for reference; always consult the original publications for complete study details. Consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Individual results may vary.

My Stack

0 treatments

🧪

Your stack is empty. Browse treatments and click + to build your protocol.